🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Missed Pietro Nardelli's talk at #PVRI2025? Now's your time to catch up!🎦 🔹CT-derived machine-learning approach to distinguish CTEPH patients from controls & acute PE cases 🔹The model leverages radiomic analysis of intraparenchymal vessels to identify key markers

Next up in our High Altitude webinar series: 🚀 "Hypoxia in Pulmonary Vascular Research – Altitude and Beyond" Join Samuel Vergès for a presentation on La Rinconada Expedition 5300 – an overview of scientific results 🗻 🗓️ 27 May 2025 🕐 1PM BST Free to attend – register now

📢 Announcing the PVRI 2026 Scientific Organising Committee! We’re excited to introduce our fantastic team shaping the scientific programme for #PVRI2026, taking place 28–31 January 2026 in Dublin. This global group of experts will bring together diverse perspectives across basic

New publication: Automated Bi-Ventricular Segmentation and Regional Cardiac Wall Motion Analysis for Rat Models of Pulmonary Hypertension by Marili Niglas Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/full/10.10…

ahajournals.org/doi/10.1161/CI…. Sasha Prisco, MD, PhD shows Lactobacillus treatment alters the micro/mycobiome improves RV function via an inflammatory-microtubule axis in Circ: Heart Failure! 3CPR Council The Pulmonary Vascular Research Institute ATS PC Assembly Microbiome Live News Ryan J Tedford MD #microtubules

📆 1 month to go – are you joining us in Amsterdam? Our Drug Discovery & Development Symposium 2025 is just a month away, and we’re counting down the days! From big conversations on the future of PH drug development to brilliant networking and an incredible speaker line-up, it’s

Huge congratulations to Sandeep Sahay, MD, MSc on receiving the ATS Outstanding Clinician Award — so well deserved! 👏site.thoracic.org/membership/awa…

Happening next week! Register for free us02web.zoom.us/webinar/regist…

New publication: Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets? by Janne Verhaegen Et al. Read the full research article➡️onlinelibrary.wiley.com/doi/10.1002/pu…

Thank you Circ: Heart Failure for the opportunity to share our work on how modulating the gut microbiome may be an approach to enhance RV function in PAH. Grateful to the entire research team for their help on this project. ATS PC Assembly 3CPR Council The Pulmonary Vascular Research Institute @GiessenPh Ryan J Tedford MD GutMicrobiota Health

Don’t miss this upcoming iPVD webinar with Yassine Sassi on 'Environmental determinants and PVDs', moderated by Rudolf Oliveira. Free and open to all! us02web.zoom.us/webinar/regist… #PulmonaryHypertension #iPVD #PVD

🚨 Exciting speaker update! We’re thrilled to welcome Illiana Meurs from the Dutch Medicines Evaluation Board (CBG-MEB) to the #DDDS2025 scientific programme. Illiana will be joining Mitchell Psotka (FDA representative, speaking virtually) to share a global perspective on the regulatory

Liquidia is proud to announce that the U.S. FDA has approved YUTREPIA™ (treprostinil) inhalation powder for patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). See today’s press release here:

🚨 Happening Tomorrow! Next in our High Altitude webinar series: La Rinconada Expedition 5300 – an overview of scientific results🏔️ Join Samuel Vergès, Grenoble Alpes University, and our moderators Aastha Mishra, CSIR-Institute of Genomics & Integrative Biology &

We are now live! Still time to join us02web.zoom.us/webinar/regist…

Could reduced levels of #PRMT1 and #PECAM1 be #biomarkers for #early #detection and prevent the development and progression of COPD? 🫰🧬🐁 Could treatment with BAY-11-7082 be the #drug of choice for COPD in the future by inhibiting the NF-κB #pathway, thereby preventing the

Happening today! 🌍 Join us for this free webinar in the iPVD Virtual Symposium Series, where Yassine Sassi will discuss Environmental Determinants and PVDs. 🗓️ 28 May | ⏰ 3PM BST 🎤 Moderated by Rudolf Oliveira 🔗 Register here: us02web.zoom.us/webinar/regist…

New publication: Arteriovenous Oxygen Content Difference: A Diagnostic Predictor for Preselecting Invasive Treatment in Congenital Heart Disease-Related Pulmonary Arterial Hypertension by Ashfaq Ahmad Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/10.1002/pu…

Join us for our June PVRI Community Call! We’re excited to welcome guest authors Breanne McCarthy, Nadine Al-Naamani, and Ricardo Amorim Corrêa as they share insights on: 🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH 🌍 Morbidity and mortality

New PAH treatment offers hope for patients in advanced stage of disease🫁Read the groundbreaking study in NEJM nejm.org/doi/full/10.10…